These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 12669107

  • 1. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
    Kulkarni SK, Naidu PS.
    Drugs Today (Barc); 2003 Jan; 39(1):19-49. PubMed ID: 12669107
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS, Sauvanaud F, Limosin F.
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopamine D3 receptor variant and tardive dyskinesia.
    Rietschel M, Krauss H, Müller DJ, Schulze TG, Knapp M, Marwinski K, Maroldt AO, Paus S, Grünhage F, Propping P, Maier W, Held T, Nöthen MM.
    Eur Arch Psychiatry Clin Neurosci; 2000 Jun; 250(1):31-5. PubMed ID: 10738862
    [Abstract] [Full Text] [Related]

  • 11. The current status of tardive dyskinesia.
    Sachdev PS.
    Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
    [Abstract] [Full Text] [Related]

  • 12. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE.
    J Clin Psychiatry; 2000 Jun; 61 Suppl 4():5-9. PubMed ID: 10739324
    [Abstract] [Full Text] [Related]

  • 13. Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia.
    Ebadi M, Hama Y.
    Neurosci Biobehav Rev; 1988 Jun; 12(3-4):179-87. PubMed ID: 2906420
    [Abstract] [Full Text] [Related]

  • 14. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Essali A, Deirawan H, Soares-Weiser K, Adams CE.
    Cochrane Database Syst Rev; 2011 Nov 09; (11):CD000206. PubMed ID: 22071797
    [Abstract] [Full Text] [Related]

  • 15. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul 09; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic measures in tardive dyskinesia].
    Tegeler J, Wöller W.
    Fortschr Neurol Psychiatr; 1983 Jun 09; 51(6):203-26. PubMed ID: 6136457
    [Abstract] [Full Text] [Related]

  • 17. Animal models of tardive dyskinesia--a review.
    Kulkarni SK, Naidu PS.
    Indian J Physiol Pharmacol; 2001 Apr 09; 45(2):148-60. PubMed ID: 11480221
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Meclofenoxate therapy in tardive dyskinesia: a preliminary report.
    Izumi K, Tominaga H, Koja T, Nomoto M, Shimizu T, Sonoda H, Imamura K, Igata A, Fukuda T.
    Biol Psychiatry; 1986 Feb 09; 21(2):151-60. PubMed ID: 2868761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.